Print page

Thomas D. Jordan

May 2006 Distinguished Alumnus

tom jordan 2014

Thomas D. “Tom” Jordan is the founder, president and chief executive officer of Tom Jordan Consulting. He is a 1970 graduate of Polk State College, known then as Polk Junior College.

Tom graduated from Lakeland High School in 1964 and then started at Polk in 1965 at the Bartow Air Base. He served as student body president and was working full-time to pay for school. In his words, he came from “nothing”, so as a way to escape the pressures of work/school/home, he joined the Army. He later returned to Polk and graduated in 1970 with an AA degree. Later, Tom graduated from the University of Florida with an advertising degree in 1972, and received his MBA from Xavier University in 1981.

He joined Pfizer, as a sales representative, in 1974 and moved to Adria Laboratories (the first cancer drug company in the US) in 1976.  He ultimately became the National Sales Manager at Adria.  After seven years with them, he joined Bristol-Myers Squibb as a product manager.  Following numerous promotions, he became the Vice President of their Worldwide Oncology Business. His responsibility led to his global travels to more than 50 countries.

Tom retired from Bristol-Myers Squibb in 2001, founding his own oncology consulting company, Tom Jordan Consulting.  His company provides consulting services in sales, marketing, legal, regulatory, licensing and business development, and cancer drug development, to companies in the US and Japan.  His client list has included the American Society of Clinical Oncology (ASCO, the global organization for oncologists), the International Association for the Study of Lung Cancer (IASLC) and the International Society of Gynecologic Oncology.  His business client list has included such companies as, Bristol-Myers Squibb, Johnson & Johnson and Procter & Gamble.

Tom was an honor graduate at the University of Florida in 1972. During his military service Tom was awarded the Vietnam Service Medal, Army Commendation Medal and in 1972, served in the Pentagon, as Aide-de-Campe to the Chief, US Army Reserve. During his career in cancer drug development, he was recognized by ASCO with its Appreciation Award in 2001, and again in 2007. He was a member of the Board of Trustees for the Oncology Nursing Society (ONS) Foundation for six years, and the organization created the “Thomas D. Jordan Doctoral Scholarship” in his honor. This is awarded annually by ONS. He was awarded the Oncology Nursing Society “Friend of the Foundation” in 1998. The IASLC awarded Tom its Award of Appreciation in 1997, and in 2000 recognized him with its Distinguished Service Award.  IASLC also created two travel fellowships in his name. He was recognized as the Cancer Care Honoree in 2004.  Tom is an active member of the Benevolent and Protective Order of Elks, as served as the treasurer of the Manila Lodge 761 in 2012 to 2013.

Tom continues his consulting business and lives outside Manila, Philippines with his wife, Jing, and their son.  He feels the greatest success of his career was the introduction of the anti-cancer drug, Taxol (paclitaxel). He named it, priced it, marketed it, and launched the drug worldwide. Taxol has benefited thousands of cancer patients who have received it.